When I was diagnosed with colon cancer, I had a hard time deciding what my legacy should be, but once I realized what it was, ...

Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.

Circulating tumor cell (CTC) count can help inform treatment decisions for patients with cancer, including which patients are ...

Danziten, a new formulation of nilotinib, may improve treatment adherence in patients with Philadelphia chromosome-positive ...